secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K/A
Filed at:   2023-04-04T23:59:59+00:00
Accession:  0001193125-23-090853
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica files audited FY2022 financials post-reverse merger; net loss $14.5M
--------------------------------------------------------------------------------

- Net loss of $14.5M in 2022, accumulated deficit $118.4M as of Dec 31, 2022.
- Cash and cash equivalents $1.3M at year-end 2022; merger and private placement raised ~$34.2M in March 2023.
- Reverse merger closed March 20, 2023; Graybug Vision renamed CalciMedica, surviving as public entity.
- Former CalciMedica stockholders own ~72% of combined company on fully diluted basis.
- Going concern opinion included; management expects new funds to support operations beyond 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523090853/0001193125-23-090853-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523090853/d471673d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-090853

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer